Saving money is wise, but investing is profitable
In accordance with the legislation of the Czech Republic, the Company provides services only to qualified investors!

News

Finance and investment news.
Forma Therapeutics Holdings Incorporated (FMTX) Financial results for the second quarter of 2020
Net loss per share – US$4.58. Cash and cash equivalents were US$414.3 million as of June 30, 2020, compared to $173.2 million as of December 31, 2019.
Vaxcyte Incorporated (PCVX) Financial results for the second quarter of 2020
Net loss per share – US$1.72. Cash and cash equivalents were $410.0 million as of June 30, 2010, compared to $59.0 million as of December 31, 2019.
Vroom Incorporated (VRM) Financial results for the second quarter of 2020
Non-GAAP net loss per share - US$0.34. Net loss per share - US$2. Revenue - $253.1 million. This is 3.0% less than in the same period of the previous year.
Lemonade Incorporated (LMND) Financial results for the second quarter of 2020
Net loss per share - US$1.77. This is $0.41 better than was forecasted. Revenue - US$29.9 million. This is 116.7% more than in the previous year.
IPO of DCT Industrial Trust Incorporated.
Duck Creek Technologies increased its IPO price range from $19-21 to $23-25 per share.  In 2020 companies raised over US$60 billion in IPO, which is the best result from the times of the tech bubble in 2000.
Inari Medical Incorporated (NARI) Financial results for the second quarter of 2020
GAAP income per share – $0.16 Revenue – $25.39 million, +152.1%, compared to the same period of the previous year.
Fusion Pharmaceuticals Incorporated (FUSN) Financial results for the second quarter of 2020
Net loss - $18.91 per share, with consensus forecast - $0.49. The company holds cash of $319 million.
Burning Rock Biotech Limited (BNR) Financial results for the second quarter of 2020
Net loss per share – $0.38 Revenue – RMB107.0 million (US$15.1 million). This is 26.1% more than for the same period in 2019.
ZoomInfo Technologies Incorporated (ZI) Financial results for the second quarter of 2020
Non-GAAP income per share – $0.07. GAAP income per share – $0.22 Revenue – $110.9 million (+ 61.9% year-over-year)
CureVac B.V. is going public
German biopharmaceutical company from Tübingen develops therapeutic entities based on messenger ribonucleic acid (“mRNA”).
Duck Creek Technologies Incorporation is making an IPO.
The IPO of Duck Creek Technologies Incorporation (DCT) will take place on August 13, 2020. Duck Creek is a leading provider of the Saas software for the P&C insurance industry.